Event Details
AcelRx Pharmaceuticals Names Howard B. Rosen as Chief Executive Officer and Provides Update on Clinical Development Activities and Corporate Priorities for 2016
Mar 29, 2016 from at 4:30 PM to 4:30 PM EDT
Supporting Materials
AcelRx_20160329_430PME.mp3 5.6 MB
